Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · IEX Real-Time Price · USD

4.100

+0.060 (1.49%)

At close: Jul 2, 2024, 4:00 PM

4.180

+0.080 (1.95%)

After-hours: Jul 2, 2024, 7:02 PM EDT

Xenetic Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-4.13	-6.55	-5.65	-10.89	-18.06	Upgrade
Depreciation & Amortization	0	0.03	0.04	0.03	0.03	Upgrade
Share-Based Compensation	0.28	0.51	0.41	0.47	0.81	Upgrade
Other Operating Activities	-0.26	1.37	0.46	6.13	5.54	Upgrade
Operating Cash Flow	-4.11	-4.65	-4.74	-4.27	-6.4	Upgrade
Capital Expenditures	0	0	0	0	0	Upgrade
Acquisitions	0	-0.5	0	0	0	Upgrade
Investing Cash Flow	0	-0.5	0	0	0	Upgrade
Share Issuance / Repurchase	0	0	11.45	5.43	16.13	Upgrade
Financing Cash Flow	0	0	11.45	5.43	16.13	Upgrade
Net Cash Flow	-4.11	-5.15	6.72	1.16	9.73	Upgrade
Free Cash Flow	-4.11	-4.65	-4.74	-4.27	-6.4	Upgrade
Free Cash Flow Margin	-161.98%	-272.23%	-408.21%	-976.60%	-37486.25%	Upgrade
Free Cash Flow Per Share	-2.69	-3.27	-4.61	-6.67	-22.43	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).